Skip to main content

ORIGINAL RESEARCH article

Front. Genet.

Sec. Computational Genomics

Volume 16 - 2025 | doi: 10.3389/fgene.2025.1580512

This article is part of the Research Topic Using various physical and genomics markers for smart therapy by expert systems with computer learning: Volume II View all articles

A Novel End-to-End Learning Framework for Inferring LncRNA-Disease Associations based on Convolution Neural Network

Provisionally accepted
Shunxian Zhou Shunxian Zhou 1Lei Wang Lei Wang 2*Sisi Chen Sisi Chen 3*Jinhai Le Jinhai Le 3*Taiyang Xu Taiyang Xu 4
  • 1 Hunan Women'S University, Changsha, Hunan Province, China
  • 2 Changsha University, Changsha, China
  • 3 The First Hospital of Hunan University of Chinese Medicine, Changsha, Hunan, China
  • 4 Changsha Rail Transit Institute, Changsha, China

The final, formatted version of the article will be published soon.

    In recent years, lots of computational models have been proposed to infer potential lncRNA-disease associations. In this manuscript, we introduced a novel end-to-end learning framework named CNMCLDA, in which, we first adopted two convolutional neural networks to extract hidden features of diseases and lncRNAs separately. And then, by combining these hidden features of diseases and lncRNAs with known lncRNA-disease associations, we designed 5 different loss functions. Next, based on errors obtained by these loss functions, we would perform back propagation to fit parameters in CNMCLDA, and complete those missing values in lncRNA-disease relational matrix according to these fitted parameters. In order to demonstrate the prediction performance of CNMCLDA,, intensive experiments have been carried out and experimental results show that CNMCLDA can achieve better performances than state-of-the-art competitive predictive models in frameworks of five-fold cross validation, ten-fold cross validation and leave-one-disease-out cross validation respectively. Moreover, in case studies of gastric cancer, glioma and breast cancer, there are 19, 17 and 16 out of top 20 candidate lncRNAs inferred by CNMCLDA having been confirmed by recent relevant literatures separately, which demonstrated the outstanding performance of CNMCLDA as well. Hence, it is obvious that CNMCLDA may be an effective tool for prediction of potential lncRNA-disease associations in the future.

    Keywords: lncRNA-disease associations, computational model, Prediction model, Convolutional Neural Network, Negative samples

    Received: 20 Feb 2025; Accepted: 31 Mar 2025.

    Copyright: © 2025 Zhou, Wang, Chen, Le and Xu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Lei Wang, Changsha University, Changsha, China
    Sisi Chen, The First Hospital of Hunan University of Chinese Medicine, Changsha, Hunan, China
    Jinhai Le, The First Hospital of Hunan University of Chinese Medicine, Changsha, Hunan, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

    Research integrity at Frontiers

    Man ultramarathon runner in the mountains he trains at sunset

    95% of researchers rate our articles as excellent or good

    Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


    Find out more